SPONSOR
Shanghai Jiaolian Drug Research and Development Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 3
Shanghai Jiaolian Drug Research and Development Co., Ltd is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Primary Membranous Nephropathy, Pemphigus.
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Jiaolian Drug Research and Development Co., Ltd
How many clinical trials has Shanghai Jiaolian Drug Research and Development Co., Ltd sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shanghai Jiaolian Drug Research and Development Co., Ltd, of which 2 are actively recruiting participants. These trials cover conditions including Primary Membranous Nephropathy, Pemphigus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Jiaolian Drug Research and Development Co., Ltd research focus on?
Shanghai Jiaolian Drug Research and Development Co., Ltd clinical trials span Primary Membranous Nephropathy, Pemphigus. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Jiaolian Drug Research and Development Co., Ltd clinical trial?
To participate in a Shanghai Jiaolian Drug Research and Development Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Jiaolian Drug Research and Development Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Shanghai Jiaolian Drug Research and Development Co., Ltd
NCT05668403 Phase 1
Recruiting
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Primary Membranous Nephropathy
NCT06454357 Phase 2, Phase 3
Recruiting
A Clinical Study of B007 in the Treatment of Pemphigus.
Pemphigus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology